Maynard Um
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 16c
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals appoints Dr. Matt Cohen to its board of directors
-
-
-
-
-
-
-
Morgan Stanley Upgrades Arrowhead Pharma (ARWR) to Overweight
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Inc. (ARWR) Tops Q1 EPS by 10c
-
-
-
-
-
-
-
Bernstein on Arrowhead Pharma (ARWR): 'Obesity Data Meets Our Solid Win Scenario'
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised at Bernstein Ahead of Obesity Data Update
-
-
-
-
-
-
-
Arrowhead Pharma (ARWR) PT Raised to $80 at RBC Capital
-
464,009 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


